Literature DB >> 29566211

Is Kt/V useful in elderly dialysis patients? Pro and Con arguments.

James Tattersall1, Ken Farrington2,3, Giorgio Gentile4, Jeroen Kooman5, Juan F Macias Núñez6, Ionut Nistor7, Wim Van Biesen8, Adrian Covic7.   

Abstract

Current guidelines for dialysis specify a minimum Kt/V. For haemodialysis (HD) patients, minimum treatment time and frequency is also specified. The guidelines allow for modification to take account of renal function. The guidelines are not specifically aimed at the elderly and may not be appropriate for all patients in this group. Increasing age is accompanied by physiological and pathological changes that may modify the patient's response to uraemia and dialysis. Frailty and multi-morbidity are likely, but to a variable extent. Elderly patients could be more susceptible to the effects of uraemia and require a higher dose of dialysis. Conversely, the generation rate of uraemic toxins is lower in elderly patients, potentially reducing the need for dialysis. In the elderly, quality of life may be more adversely affected by multimorbidity than uraemic symptoms, thus the dose of dialysis may be less relevant. Higher doses of dialysis may be more difficult to achieve in the elderly and may be less well tolerated. We conclude that the prescription of dialysis in the elderly should be individualized, taking multiple factors into account. An individualized Kt/V may be useful in controlling dialysis dose and detecting problems in delivery. However, achievement of a specified Kt/V may not result in any benefit to an elderly patient and could be counterproductive.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29566211     DOI: 10.1093/ndt/gfy042

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Optimizing dialysis dose in the context of frailty: an exploratory study.

Authors:  Sandra Y Hernandez-Agudelo; Carlos G Musso; Henry J González-Torres; Christian Castro-Hernández; Lina P Maya-Altamiranda; María V Quintero-Cruz; Claudio Corradino; Sergio A Terrasa; Gustavo J Aroca-Martínez; Andrés Cadena-Bonfanti
Journal:  Int Urol Nephrol       Date:  2021-01-30       Impact factor: 2.370

2.  No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.

Authors:  Gang Jee Ko; Yoshitsugu Obi; Melissa Soohoo; Tae Ik Chang; Soo Jeong Choi; Csaba P Kovesdy; Elani Streja; Connie M Rhee; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2018-11-13       Impact factor: 3.754

3.  Renal Association Clinical Practice Guideline on Haemodialysis.

Authors:  Damien Ashby; Natalie Borman; James Burton; Richard Corbett; Andrew Davenport; Ken Farrington; Katey Flowers; James Fotheringham; R N Andrea Fox; Gail Franklin; Claire Gardiner; R N Martin Gerrish; Sharlene Greenwood; Daljit Hothi; Abdul Khares; Pelagia Koufaki; Jeremy Levy; Elizabeth Lindley; Jamie Macdonald; Bruno Mafrici; Andrew Mooney; James Tattersall; Kay Tyerman; Enric Villar; Martin Wilkie
Journal:  BMC Nephrol       Date:  2019-10-17       Impact factor: 2.388

Review 4.  Incremental hemodialysis, a valuable option for the frail elderly patient.

Authors:  Carlo Basile; Francesco Gaetano Casino; Filippo Aucella
Journal:  J Nephrol       Date:  2019-04-19       Impact factor: 3.902

5.  Incremental and Personalized Hemodialysis Start: A New Standard of Care.

Authors:  Massimo Torreggiani; Antioco Fois; Antoine Chatrenet; Louise Nielsen; Lurlynis Gendrot; Elisa Longhitano; Léna Lecointre; Claudine Garcia; Conrad Breuer; Béatrice Mazé; Assia Hami; Guillaume Seret; Patrick Saulniers; Pierre Ronco; Frederic Lavainne; Giorgina Barbara Piccoli
Journal:  Kidney Int Rep       Date:  2022-02-19

6.  Prevalence of chronic kidney disease-associated pruritus, and association with sleep quality among hemodialysis patients in Pakistan.

Authors:  Inayat Ur Rehman; Syed Munib; Amutha Ramadas; Tahir Mehmood Khan
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

7.  Ensuring hemodialysis adequacy by dialysis dose monitoring with UV spectroscopy analysis of spent dialyzate.

Authors:  Li Zhang; Wenhu Liu; Chuanming Hao; Yani He; Ye Tao; Shiren Sun; Marten Jakob; Daniele Marcelli; Claudia Barth; Xiangmei Chen
Journal:  Int J Artif Organs       Date:  2021-11-23       Impact factor: 1.595

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.